摩根中国生物医药混合(QDII)A(001984)
2025-12-30
1.3586
-1.2071%
| 报告期 |
证券买卖差价收入 |
投资收益 |
回购收入 |
其他收入 |
合计 |
| 2025-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 13,196.74 |
| 2024-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -7,703.46 |
| 2024-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -7,793.37 |
| 2023-12-31 | 0.00 | 0.00 | 32.71 | 0.00 | -17,995.28 |
| 2023-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -13,529.56 |
| 2022-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -32,179.50 |
| 2022-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -17,707.02 |
| 2021-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -1,014.54 |
| 2021-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 28,641.32 |
| 2020-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 61,018.80 |
| 2020-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 60,577.78 |
| 2019-12-31 | 0.00 | 0.00 | 1.91 | 0.00 | 8,902.71 |
| 2019-06-30 | 0.00 | 0.00 | 1.91 | 0.00 | 1,902.79 |
| 2019-02-21 | 0.00 | 0.00 | 0.00 | 0.00 | -1.74 |
| 2018-12-31 | 0.00 | 0.00 | 0.38 | 0.00 | -348.32 |
| 2018-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -116.79 |
| 2017-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 1,539.42 |
| 2017-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 1,105.53 |
| 2016-12-31 | 0.00 | 0.00 | 25.26 | 0.00 | 9.53 |
| 2016-06-30 | 0.00 | 0.00 | 25.26 | 0.00 | 145.14 |
